Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) [clinicaltrials:NCT00236041]
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) [clinicaltrials:NCT00236041]
Bio2RDF identifier
NCT00236041
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00236041
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The primary objective o ...... with an optimal ACTIQ dosage.
brief title [clinicaltrials_vocabulary:brief-title]
Efficacy/Safety Study of ACTIQ ...... s With Breakthrough Pain (BTP)
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2006-08-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The primary objective o ...... linical measures of analgesia
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-10-07T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
Adolescents
Breakthrough Pain
Non-Cancer
Severe Burns
Sickle Cell Disease
Sickle Cell
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-05-08T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00236041
official title [clinicaltrials_vocabulary:official-title]
A Double-Blind, Placebo-Compar ...... escents With Breakthrough Pain
org study id [clinicaltrials_vocabulary:org-study-id]
C8278b/202/BP/US-CA
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2004-04-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2014-05-01T00:00:00Z
identifier
clinicaltrials:NCT00236041
title
Efficacy/Safety Study of ACTIQ ...... s With Breakthrough Pain (BTP)
@en
type
label
Efficacy/Safety Study of ACTIQ ...... ) [clinicaltrials:NCT00236041]
@en